| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 26.154 | 33.521 | 45.931 | 47.401 | 53.055 | 64.430 | 72.602 | 93.951 |
| Total Income - EUR | - | 0 | 26.155 | 33.521 | 45.932 | 47.402 | 53.056 | 77.409 | 73.107 | 93.966 |
| Total Expenses - EUR | - | 326 | 10.626 | 12.041 | 19.093 | 23.472 | 30.208 | 50.672 | 40.815 | 51.484 |
| Gross Profit/Loss - EUR | - | -326 | 15.528 | 21.480 | 26.839 | 23.930 | 22.848 | 26.737 | 32.292 | 42.482 |
| Net Profit/Loss - EUR | - | -326 | 15.245 | 21.119 | 26.379 | 23.468 | 22.328 | 26.030 | 31.589 | 39.719 |
| Employees | - | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr.feta Merihan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 18.615 | 0 | 64.834 | 57.975 |
| Current Assets | - | 268 | 15.485 | 36.372 | 67.717 | 56.213 | 42.114 | 32.297 | 27.218 | 27.983 |
| Inventories | - | 0 | 61 | 0 | 0 | 695 | 0 | 0 | 8 | 0 |
| Receivables | - | 45 | 1.188 | 0 | 0 | 0 | 0 | 1.272 | 8.255 | 1.059 |
| Cash | - | 224 | 14.236 | 36.372 | 67.717 | 55.517 | 42.114 | 31.024 | 18.956 | 26.924 |
| Shareholders Funds | - | -282 | 14.968 | 35.812 | 61.498 | 57.958 | 44.641 | 32.191 | 37.730 | 45.826 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 550 | 517 | 559 | 6.219 | -1.746 | 16.087 | 106 | 54.322 | 40.132 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr.feta Merihan Srl